Access cutting-edge metastatic melanoma treatment through this clinical trial at a research site in Lancaster. Study-provided care at no cost to qualified participants.
Access metastatic melanoma specialists in Lancaster at no cost
This study follows strict safety protocols and ethical guidelines
All study-related metastatic melanoma treatment provided free
The main purpose of this study is to determine the safety of combining ipilimumab and nivolumab with hypofractionated radiotherapy to a single tumor in patients with metastatic melanoma. Another purpose of this study is to determine the effect of ipilimumab, nivolumab and hypofractionated radiotherapy on the cancer as compared to ipilimumab and nivolumab.
Sponsor: Abramson Cancer Center at Penn Medicine
Check if you qualify for this metastatic melanoma clinical trial in Lancaster, PA
If you're searching for metastatic melanoma treatment options in Lancaster, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lancaster research site is actively enrolling participants for this clinical trial. You'll receive care from experienced metastatic melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.